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INTRODUCTION
The anthrax alert tested health care in
2001
Year 2001 was epidemiologically relatively un-
eventful. The exception was the ’flour letter
outbreak’ in the postal system, which followed
the anthrax cases in USA caused by
bioterrorism. This ’alert exercise’ tested the
skills and capabilities of the health, police,
environmental and civil protection authorities
to act together in a co-ordinated manner un-
der exceptional pressure. Predominantly the
experiences from the collaboration were fa-
vourable, but also weaknesses in response ca-
pabilities were revealed. It became evident that
improving the resources and capabilities to
detect, investigate and control a bioterrorism
incident needs to involve all levels of the ex-
isting organisations responding to outbreaks
and epidemics. A separate bioterrorism re-
sponse organisation should not be established,
as the necessary methods and experience are
identical. In addition, the organisations need
knowledge and experience on rare pathogens,
as well as trained reserve capacity, which can
be mobilised.
Favourable developments included the
decrease in the incidence of tuberculosis for
the first time below 10 cases per 100 000 in-
habitants, and the fall of laboratory confirmed
cases of whooping cough to less than half of
that during the preceding year, after a
consistent increase for many years in the late
1990s.
Of concern are the two cases of diphthe-
ria, one of them in an non-immunised new-
born with no traceable connection to travel.
Development of the Infectious Disease
Register supports the revision of the
vaccination program
New challenges for development are in sight.
In 2005, the healthy baby clinics will adopt a
revised national vaccination program, in
which the key change is the introduction of an
acellular vaccine against whooping cough as
part of a combination vaccine with five or six
components. In the 2002-2003 influenza sea-
son vaccination against influenza will be of-
fered for the first time in the national vaccina-
tion program to everyone aged 65 or older.
In addition, the city of Helsinki plans to
offer pneumococcal polysaccharide vaccine to
everyone aged 65 or older in the autumn of
2002. The surveillance for whooping cough,
influenza and serious pneumococcal infections
will be strengthened to assess the impact of
these changes.
Data from the surveillance system and
morbidity in the population
The proportion of findings notified electroni-
cally by the laboratories to the infectious dis-
ease register has continuously increased, and
reached 70 % in 2001. This facilitates even
faster transmission of data and information
than before, which strengthens the use of this
system in detecting epidemics and monitor-
ing them. More than one half of the microbial
findings causing respiratory infections are in
the national register within one week from the
collection of the sample, but the delay is at least
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11 days in one quarter of the notifications,
and at least three weeks in one tenth. This is
excluding the findings based on paired sera.
For providing as updated, and consequently
most useful, data as possible the laboratories
should notify their findings within one week
from establishing the laboratory test result,
preferably without any delay.
The figures on most infections under sur-
veillance by the register do not directly meas-
ure the burden of disease caused by the infec-
tion (Figure 1).  Only a small proportion of the
patients falling ill with common diseases such
as respiratory and acute intestinal infections
seek health care and will undergo microbio-
logical testing. However, when the health care
and surveillance systems remain stable, these
figures reflect well temporal trends. In order
to assess the total disease burden caused by
these diseases or causative microbial agents,
e.g. for planning and justifying large-scale con-
trol measures, separate population based sur-
veys need to be implemented. These will as-
certain the proportion of the overall true mor-
bidity in the population that is detected by the
continuous surveillance system. It has been
observed in surveys in different countries that,
for example, the true number of cases in the
population of salmonella infections is 4 to 40
times greater than that observed in the con-
tinuous surveillance system. In serious dis-
eases such as tuberculosis and serious menin-
gococcal infection patients seek health care,
which performs comprehensive microbiologi-
cal diagnostics. The figures from surveillance
of these infections reflect well the total bur-
den of disease.
The annual report aims at giving the
annual statistics on the diseases under surveil-
lance as well as comment acute events of the
particular year and definitive changes in short
term trends. As the time span of the infectious
disease register, established in 1995, grows, the
possibilities for more analytic use of the mi-
crobial and disease findings increase. More
comprehensive analytic research is going on
regarding the epidemiology of invasive infec-
tions caused by pneumococcus, Streptococcus
agalactiae and Staphylococcus aureus. The micro-
bial strains sent to the isolate collection of the
infectious disease register further strengthen
the possibilities to exploit the data.
Test positive,
 not notified to KTL 
Test positive,
notified to KTL
Visited physician,
no notification
Symptoms, which did not lead
to a visit to physician
Very mild or symptomless infection 
Test negative 
Figure 1.
The relationship of the number of notifications to infections in the population
Petri Ruutu
Chief,
Surveillance and epidemiologic investigation
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RESPIRATORY INFECTIONS
Influenza A, B and parainfluenza
Influenza A cases were clearly fewer than in
the preceding two years. However, the number
of influenza B cases was more than double the
average of previous years. In 2001 notifications
were also done on non-typed influenza virus.
These are based on rapid tests that do not dif-
ferentiate between influenza A and B. These
non-typed cases constituted nearly one quar-
ter of all findings for influenza.
Parainfluenza cases were more numer-
ous than before, nearly double compared to
the preceding years.
Figure 2.
Influenza A, B and parainfluenza
in  2001
Figure 3.
Influenza A
January 1995 – March 2002
Cases notified
Influenza A
61%
( 932 cases )
Non-typed
23 %
( 369 cases )
Influenza B
16 %
( 250 cases )
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Legionella
Seventeen Legionella cases were notified,
which is approximately twice as many as in
the preceding years. Approximately half of the
cases had travelled abroad prior to falling ill.
The diagnosis was based on the detection of
antigen in urine in four cases, which is more
than in the previous years, and suggests the
increasing use of this diagnostic method.
Figure 4.
Respiratory syncytial virus (RSV)
January 1995 – March 2002
Cases notified
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Table 1.
Distribution of whooping cough cases by
age and sex in 2001
0
20
40
60
80
100
120
140
160
2000 200219991998199719961995 2001
Age male female total cases/
100 000 pop.
0 3 8 11 19,7
1 2 1 3 5,3
2 - 2 2 3,5
3 1 1 2 3,5
4 4 1 5 8,4
5 4 2 6 9,9
6 3 8 11 17,4
7 3 3 6 9,2
8 2 10 12 18,4
9 7 10 17 25,3
10 11 8 19 28,8
11 11 8 19 28,6
12 11 9 20 31,0
13 9 5 14 21,7
14 6 8 14 44,8
15 3 3 6 9,6
16 6 2 8 12,4
17 4 4 8 12,0
18 3 3 6 8,8
19 2 1 3 4,4
20 - 1 1 1,5
>20 31 91 122 3,2
total 126 189 315 6,1
Whooping cough – Bordetella pertussis
The number of notified Bordetella pertussis cases
was smaller than during any preceding year
between 1995-2001. The number was clearly
less than half of the average during preceding
years, and only one third of that in 2000. A
decrease was observed in all age groups and
healthcare districts, but it was strongest in
those healthcare districts with the highest in-
cidence in the preceding years.
Figure 5.
Bordetella pertussis
January 1995 – March 2002
Cases reported per month
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Table 2.
Distribution of cases of  Mycoplasma
pneumoniae by age and sex in  2001
0
20
40
60
80
100
120
140
160
1995 1998 1999 2000 2001 20021996 1997
Age male female total
0-4 43 32 75
5-9 90 75 165
10-14 91 94 185
15-19 93 62 155
20-24 43 36 79
25-29 14 32 46
30-34 12 58 70
35-39 23 54 77
40-44 23 40 63
45-49 12 31 43
50-54 8 22 30
55-59 1 10 11
60-64 1 4 5
65-69 1 3 4
70-74 1 - 1
75- - 2 2
total 456 555 1 011
Mycoplasma - Mycoplasma pneumoniae
The number of notified Mycoplasma pneumoniae
cases was one quarter higher than in 2000 and
three times as many as the average number of
cases in 1997-1999. The age distribution does
not differ from that observed during the last
six years.
Figure 6.
Mycoplasma pneumoniae
January 1995 – March  2002
Cases notified per month
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INTESTINAL INFECTIONS
The number of campylobacter notifications has
steadily increased since 1997. In 2001, 3969 in-
fections were notified, which is approximately
400 more than the year before. Also the number
of shigella notifications (223 cases) increased
considerably from previous years. Only 18
EHEC cases were notified, which is clearly less
than during the previous three years. The
number of salmonella and yersinia cases was
about at the same level as before.
Salmonella outbreak in Riga
In May 2001, approximately half of a Finnish
tourist group with 40 members fell ill with di-
arrhoea after a trip to Riga. The outbreak was
investigated in collaboration with Latvian
health authorities. A questionnaire study and
microbiological findings confirmed that the
source of infection was a yoghurt cake served
in a restaurant in Riga. Salmonella Enteritidis
PT4, which was resistant to nalidixic acid, was
isolated from patient samples. In Riga, a sal-
monella strain was isolated from a yoghurt
cake of the same batch, and further investiga-
tions confirmed that this strain also was S.
Enteritidis PT4.
Yersinia pseudotuberculosis outbreak
Since 1997 at least one Yersinia pseudotubercu-
losis outbreak has occurred every year, and
2001 was not an exception. Since May 2001,
cases were detected in different parts of Fin-
land. Altogether 59 infections were diagnosed
during the outbreak. A large case-control study
was carried out to determine the source of the
outbreak (45 cases, 180 controls). An associa-
tion between Chinese cabbage and illness was
found in the investigation. Two previous case-
control studies (in 1998 and 1999) showed
an association between iceberg lettuce and
illness. Together the studies confirm that
domestic salad products may be an important
source of yersinia infections.
Shigella sonnei outbreak in Kouvola
In August 2001, a few Shigella sonnei infections
were found among visitors to Tallinn. Later,
Shigella sonnei infections were found also in
Kymenlaakso healthcare district among per-
sons who had not been abroad. Further inves-
tigations revealed that these persons had had
lunch in the same popular restaurant. An em-
ployee of the restaurant had been in Tallinn in
August and had become ill with gastroenteri-
tis. Two other staff members were also infected.
They were not treated with anti-microbials and
returned to work before the cause of the out-
break was solved. The restaurant was closed
immediately when the suspicion of the source
was raised. During the outbreak, 41 shigella
cases were detected; 40 of them had eaten in
the restaurant and one was the child of a per-
son infected in the restaurant.
(Kansanterveys 8-9/2001)
Waterborne outbreak in Kangaslampi
In August 2001, about 50 persons in
Kangaslampi (close to the town of Varkaus)
fell ill with gastroenteritis. Campylobacter jejuni
was isolated from stool samples of sympto-
matic persons. Campylobacter was not de-
tected from water samples. However, a ques-
tionnaire study showed an increased risk of
illness among those who had drunk mains
water. The water system was probably con-
taminated with campylobacter during main-
tenance and cleaning work carried out before
the onset of the outbreak.
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Waterborne outbreak in Vihti
In October 2001, approximately 1000 people
fell ill with gastroenteritis in Vihti. Suspicion
of a waterborne outbreak was raised from the
very beginning, and a boil-water notice was
issued and water chlorination started.
Campylobacter jejuni was isolated from more
than 50 stool samples. Also samples from a
ground water well of the municipal water sys-
tem yielded C. jejuni. Environmental samples
taken from the immediate surroundings of the
well also yielded C. jejuni. Flooding close to
the contaminated water source may have re-
sulted in infiltration of bacteria to the ground
well water. The contaminated well is currently
taken out of use.
Waterborne outbreaks caused by
campylobacter in Finland
Four large campylobacter outbreaks caused by
contaminated municipal mains water have
occurred in the country between 1998 and
2001. Three of them have been in August. The
exact mechanism of contamination has re-
mained unclear, but investigation of each wa-
ter system has revealed several risk sites,
where the contamination may have occurred.
Thus, it seems that in Finland more should be
invested in the safety of ground water systems.
Infectious diseases in Finland 200112
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Figure 7.
The 12 month moving average in 1995-2001 of Salmonella and Camplylobacter cases
The moving average of cases
Figure 8.
Cases of Yersinia enterocolitica and Yersinia pseudotuberculosis in 1995-2001
Cases notified
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Data of the Infectious Disease Register have been supplemented with the data of the Laboratory of
Enteric Bacteria (1995-2001)
1995 1996 1997 1998 1999 2000 2001
Domestically acquired infections
 total 5 13 11 8 5 9 59
Infections acquired abroad
 total 67 82 84 73 62 60 161
India 16 14 20 8 2 10 10
Turkey 8 15 3 20 6 2 6
Egypt 3 8 9 1 11 15 52
Country of transmission not notified
 total 1 12 9 7 4 6 3
All cases
 total 73 107 104 88 71 75 223
Shigella infections acquired domestically or during travel in 1995-2001
Figure 4.
Figure 9.
The incidence of listeriosis in 1995-2001
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Method of transmission of acute hepatitis B and of all hepatitis C cases in 2001
Method of transmission* Acute hepatitis B All hepatitis C
injecting drug use 28 777
sex 42 41
perinatal - 2
blood products** 1 18
not known/not notified 56 652
Distribution of cases of acute hepatitis B
and all the cases of hepatitis C by age and
sex in 2001
 **  Most of the infections have been acquired outside Finland or before 1994. In three cases there is no
further information.
*   Method of transmission informed by physicians
Acute All
hepatitis B hepatitis C
Age male female male female
0-4 1 - 30 19
5-9 - 1 - 1
10-14 1 1 - 2
15-19 6 9 99 95
20-24 8 8 257 102
25-29 12 5 178 70
30-34 14 2 158 59
35-39 10 3 100 45
40-44 9 5 72 25
45-49 8 2 65 24
50-54 5 6 24 10
55-59 3 1 9 6
60-64 1 - 3 5
65-69 2 - 5 5
70-74 - - 4 5
75- 3 1 4 9
total 83 44 1008 482
HEPATITIS
Hepatitis B (HBV) and hepatitis C (HCV)
The number of new hepatitis B- and C- infec-
tions shows a slight but significant decrease
compared to previous years. The number of
cases classified as acute hepatitis B is 50 per
cent smaller than the long-term average since
1995. An increasing number of HBV vaccina-
tions has been administered among risk
groups for several years probably contribut-
ing to this.
The number of notified hepatitis C is 300-
400 cases smaller than the average of the pre-
vious years, a significant decrease. Preventive
work among drug addicts, such as needle ex-
change programmes may explain this. Age
distribution is, however, still weighted to-
wards the young age groups, most cases hav-
ing been notified among those 20-29 year old,
but a number of cases have also been notified
among those 15-19 year old. Forty-nine cases
were reported among children less than 5
years old which is in accordance with previ-
ous estimates that about 50 HCV-positive
women deliver a baby annually. Only very
few become infected but antibodies from the
mother are detectable for several months ex-
plaining most of the findings.
Figure 5
Table 6.
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Figure 10.
Hepatitis C cases aged 15-19 in 1995-2001
Acute hepatitis B and all hepatitis C cases in 1995-2001
Cases notified
Cases notified
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SEXUALLY TRANSMITTED DISEASES
Chlamydial infection – Chlamydia trachomatis
cases were detected in the eastern part of Fin-
land, in the healthcare districts of Pohjois-
Karjala and Kymenlaakso. In men 49% of the
cases were imported, mainly from Russia
(42%) and Thailand (23%). N. gonorrhoeae
strains resistant to ciprofloxacin were mainly
imported from the Far East. Women
contracted gonorrhoea in Finland (89%) and
only four cases were imported.
Syphilis – Treponema pallidum
In 2001 altogether 159 syphilis cases were re-
ported, of which 90 (56%) in men and 69 (44%)
in women. 20% of the cases were detected in
the age group of over 70 years mainly due to
serological scars of previously treated infec-
tion. There were no reports of congenital syphi-
lis. Most syphilis cases were detected in the
healthcare districts of Etelä- and Pohjois-
Karjala. In men the source country was re-
ported in 74% of the cases and 75% of the in-
fections were imported, mainly (78%) from
Russia. In women the source country was re-
ported only in 43% of the cases and 60% of
these cases were endemic.Figure 12.
Sexually transmitted diseases in 1990-2001
Cases notified (logarithmic scale)
The number of chlamydial infections has in-
creased continuously since 1995. In 2001 labo-
ratories reported 12 142 new cases The in-
crease was 411 cases compared to 2000. The
incidence of chlamydial infection was 234/
100 000 inhabitants. Chlamydial infection
was detected in 7 507 women (62%).  The
incidence was highest in the healthcare
districts of Lappi and Keski-Suomi. The
amount of chlamydial infections among ado-
lescents has increased. Of women with
chlamydial infection 35 % and of men 14%
were under 20 years of age.  One reason for
the increase of chlamydial infections might
be the increase in testing due to more sensitive
diagnostic methods from the urine.
Gonorrhoea – Neisseria gonorrhoeae
The number of gonorrhoea cases decreased
compared to 2000. In 2001 altogether 247 gon-
orrhoea cases were reported, 201 (81%) in men
and 46 (19%) in women. Most gonorrhoea
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Table 7.
Gonorrhoea, chlamydia and syphilis cases by age and sex in 2001
Gonorrhoea Chlamydia Syphilis
Age male female male female male female
0-4 - - 5 4 - -
5-9 - - - 1 - -
10-14 - - 3 50 - -
15-19 5 10 654 2 607 1 1
20-24 31 10 2 024 2 973 4 13
25-29 34 10  1 000 996 7 9
30-34 43 6 434 455 8 2
35-39 35 2 259 226 7 4
40-44 19 2 122 104 13 7
45-49 14 3 61 49 11 1
50-54 11 1 45 20 13 3
55-59 5 2 16 11 9 1
60-64 2 - 5 6 6 2
65-69 1 - 4 3 3 2
70-74 - - 1 1 1 4
75- 1 - 2 1 7 20
total 201 46 4 635 7 507 90 69
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* ) the latest infection transmitted by blood products in Finland occurred in 1985
The updated statistics on HIV/AIDS can be found on internet: www.ktl.fi/ttr
HIV/AIDS
* ) the latest infection transmitted by blood products in Finland occurred in 1985
Table 9.
AIDS in Finland 1990-2001
method of transmission
sex
year total female foreigner between- hetero- injecting blood-    peri- not
male sex drug use products*    natal known
1990 17 1 3 15 1 - - - 1
1991 27 2 1 22 4 - - - 1
1992 22 4 3 9 7 3 2 - 1
1993 25 3 2 16 5 1 3 - -
1994 43 4 5 28 13 1 - 1 -
1995 41 3 9 24 14 1 1 - 1
1996 24 2 3 16 4 2 - 1 1
1997 19 2 4 11 6 2 - - -
1998 15 3 4 7 6 - - - 2
1999 11 2 2 7 3 - - 1 -
2000 16 7 5 4 9 1 - - 1
2001 19 7 5 8 7 1 - - 2
Table 8.
HIV infections in Finland 1990-2001
method of transmission
sex
year total female foreigner between hetero- injecting blood-    peri- not
males sex drug use products*   natal known
1990 89 13 26 44 37 - 1 - 7
1991 57 10 23 21 23 1 - - 12
1992 93 21 29 34 38 5 - - 16
1993 62 16 16 18 32 4 2 - 6
1994 69 14 14 34 25 2 1 1 6
1995 72 28 22 25 40 1 - - 6
1996 69 20 29 23 36 1 - - 9
1997 71 24 19 19 42 - - 1 8
1998 81 32 22 13 32 20 - - 16
1999 143 39 18 13 28 86 - 1 14
2000 145 51 39 23 43 56 1 2 18
2001 128 33 32 27 23 48 - - 29
Infectious diseases in Finland 200120
Pulmonary tbc Tbc, other
Age male female male female         Total
0-4 - - - 1 1
5-9 1 - 1 - 2
10-14 - - - 3 3
15-19 2 2 1 1 6
20-24 3 5 3 3 14
25-29 8 5 3 2 18
30-34 11 2 3 6 22
35-39 5 8 2 2 17
40-44 13 4 - 8 25
45-49 15 7 2 3 27
50-54 19 6 3 5 33
55-59 13 5 6 2 26
60-64 21 10 5 6 42
65-69 18 7 8 8 41
70-74 21 11 8 12 52
75- 55 40 25 45 165
total 205 112 70 107 494
TUBERCULOSIS
Tuberculosis – Mycobacterium tuberculosis
The registered cases include since 1995 all cases
of tuberculosis verified by culture, as notified
by the laboratories. In addition, both the pa-
tients notified by a physician only in which
the diagnosis was notified on basis of histo-
logical proof, and cases of pulmonary tuber-
culosis with positive sputum staining for tu-
berculosis bacilli were included, as in previ-
ous years.
In 2001, tuberculosis cases (494) de-
creased by eight per cent from 2000, when there
were 537 cases. The total in 2001 was the low-
est since the NIDR started functioning in 1995.
The number of cases with culture confirma-
tion, 409, in 2001 was nine per cent lower than
in 2000 when it was 451. The overall incidence
of tuberculosis was 9,5 cases per 100 000 popu-
lation.
There were 317 cases of pulmonary tu-
berculosis (incidence 6,1 per 100 000), and 177
cases of non-pulmonary tuberculosis. Among
the pulmonary cases a positive sputum stain
for TB was reported in 49 per cent. In eight per
cent of the pulmonary cases no sputum stain
for TB was performed, or this information
was missing.
Out of all cases 375 (76 %) were based
on notifications sent by both a physician and
a laboratory, 36 (7 %) on laboratory notifica-
tion only, and 83 (17 %) on physician notifica-
tion only. As before, the notifications made by
physicians, which did not link to a laboratory
notification with a M. tuberculosis finding, were
linked to laboratory notifications on atypical
mycobacteria. Due to recently adopted con-
tinuous checking systems in the register for
reducing this misclassification, no such cases
were any more found during the compilation
of the 2001 annual report.
In 2001, tuberculosis was registered in
68 (14 % per cent of all cases) persons born
abroad or with a nationality other than Fin-
land. Among these, 60 (88 %) were below 50
years of age. Out of these cases, 41 were pul-
monary and 27 non-pulmonary.
The antimicrobial susceptibility situa-
tion in Finland is good. In 2001, four strains
with multireresistance (resistant at least to
isoniazide and rifampin) were detected.
Table 10.
The age and sex distribution of tuberculosis cases 2001
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Table 11.
RESISTANT BACTERIA
Methicillin-resistant Staphylococcus aureus (MRSA)
Over 90% of the 340 MRSA isolates notified
to the National Infectious Disease Register
were also sent to the reference laboratory at
the KTL for confirmation and further studies.
Less than 10% of all isolates sent to the
reference laboratory, and confirmed as
MRSA, lacked the notification. A total of 325
S. aureus strains were confirmed as MRSA by
the mecA-PCR method. These strains were
typed by phages and pulsed-field electro-
phoresis (PFGE), and ribotyped, if necessary.
According to molecular typing, 32 (10%) of
the strains were sporadic. The most common
strain type was Mikkeli II clone or it’s
subclones. This strain type was found all over
Finland and it caused small clusters in
hospitals. Sporadic isolates and outbreaks of
this common clone are difficult to distinguish
without more detailed local background
information. In 2001, the largest outbreaks
of MRSA occurred in Pirkanmaa (Belgium
EC-3 clone), Keski-Suomi (Kokkola clone),
and Etelä-Savo (Vaalijala clone). In the health
care district of Itä-Savo, there were also two
small clusters (Kerimäki and Kokkola clones).
None of the strains that caused outbreaks in
2001 were multi-resistant, except the one
found in Pirkanmaa.
Figure 13.
MRSA notifications 1995-2001
Cases
All notified MRSA findings and the proportion of MRSA in Staphylococcus aureus findings
from blood, 1995-2001
Year All MRSA findings S. aureus findings MRSA findings in blood and their
from blood proportion of all S. aureus findings
from blood. (%)
1995 89 627 2 (0,3)
1996 108 667 0   (0)
1997 120 746 4 (05)
1998 189 717 5 (0,7)
1999 211 812 8 (1,0)
2000 261 849 4 (0,5)
2001 344 887 4 (0,5)
total 1 322 5 305 27 (0,5)
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Table 12.
Vancomycin - resistant enterococci (VRE)
In 2001, 13 strains of VRE were sent for
further molecular characterisation. One of
these was Enterococcus casseliflavus, possessing
both vanC and vanB genes. Most of the VRE
strains were unique. One strain of
Enterococcus faecium was indistinguishable
from the strain that caused an outbreak a few
years ago in Helsinki (Helsinki I clone).
All notified S. pneumoniae findings with resistance (PRP) or reduced susceptibility to penicillin
(PIP) and the proportion of S. pneumoniae findings from blood with PRP or PIP, 1995-2001
Year PIP/PRP - S. pneumoniae PIP/PRP Reduced susceptibility to
findings* findings findings penicillin of S. pneumoniae
from blood (%)
Blood CSF Blood CSF
1995 43 478 34 4 0 0,8
1996 93 524 33 4 0 0,7
1997 146 577 29 6 0 1,0
1998 142/62 543 35 10/4 1/0 2,6
1999 171/60 548 33 11/4 1/0 2,8
2000 236/64 592 25 16/5 1/0 3,7
2001 214/67 645 13 21/6 0/1 4,3
1995-2001 1 325 3 907 202 58/33 3/1 2,4
* During 1995-1997 only S. pneumoniae findings with resistance to penicillin (PRP) were notifiable. From
1998 also findings with reduced susceptibility to penicillin (PIP) have been notified.
Penicillin-resistant pneumococcus
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serogroup 1995 1996 1997 1998 1999 2000 2001
A - - - - - - -
B 50 59 36 44 35 30 34
C 22 15 5 7 9 11 9
Y - 3 3 2 8 2 4
W135 - - - - 1 3 1
not known 6 2 2 1 4 2 3
total 78 79 46 54 57 48 51
OTHER BACTERIAL INFECTIONS
Diphtheria – Corynebacterium diphtheriae
In November 2001, a 3 month old, previously
healthy, unvaccinated infant died of diphthe-
ria in south eastern Finland. The illness began
with laryngeal cough and low grade fever, and
progressed in one week to severe respiratory
distress requiring mechanical ventilation. The
child died of toxic illness despite intensive care
and antimicrobial and antitoxin treatment.
In cultures of close contacts, a 7-year-old
sister of the patient was identified as an asymp-
tomatic carrier of C. diphtheriae. She had re-
ceived a full course of diphtheria, tetanus, and
pertussis (DTP) vaccines. All other cultures
from close contacts of both the patient and his
sister were negative. Many of the people with
whom the patient and his sister had been in
contact before the onset of illness had recently
visited Russia. According to DNA typing re-
sults, the bacterial strain appeared similar to
C. diphtheriae var mitis strains recently detected
circulating in Russia.
In December, an unvaccinated, middle-
aged man from southwestern region became
ill with sore throat and Corynebacterium
diphtheriae (biotype mitis) was cultured from
a throat swab. He recovered well with antibi-
otic therapy. The source of the infection re-
mained unknown. No carriers were identified
in throat swabs taken from close contacts and
at the work place. No direct connection to Rus-
sia was identified.
According to serological studies done in
1995-96, young adults in Finland have good
protection against diphtheria. The antibody
concentrations wane with increasing age,
however, and are substantially lower in
middle aged and older age groups. The small
number of diphtheria cases identified in
Finland in recent years despite extensive
traffic across the border implies that the
overall immunity of the population is
relatively good. Adults, however, particularly
women, should ensure that they have
received a full series of three doses of
diphtheria vaccine and booster doses every
10 years, especially when travelling to Russia
or the Baltic states.
Lyme borreliosis – Borrelia burgdorferi
The number of Borrelia cases, 691, was lower
than in the record year 2000, but definitely
higher than during all years in the late 1990s.
The highest number of cases was observed in
August and September. However, cases were
distributed throughout the year. In Ahvenan-
maa district the incidence was still very high,
almost 1 000 cases/ 100 000 population. Also
in Kymenlaakso district the incidence was
higher than the national average.
Meningococcal infection – Neisseria
meningitidis
The number of invasive meningococcal cases,
51, was of the same magnitude as during the
preceding years and the serogroup distribution
unchanged. The rare serogroup W135, which
in 2001 caused one case, has been associated
with pilgrimage journeys to Saudi Arabia. In
this case, however, there was no travel
background.
Cases of invasive meningococcal infection by serogroup in 1995-2001
Table 13.
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Figure 14.
Incidence of Puumalavirus cases by health
care district in 2001.
(size of hcd proportioned to
population base)
            0- 27.7
            27.8 -46.3
          46.4 -
Hib –Haemophilus influenzae type b
Altogether 49 cases of invasive Haemophilus
influenzae infection were notified, four of them
caused by serotype b. All of those with inva-
sive infection caused by Hib were at least 60
years old, except for one middle-aged case.
Tularemia – Francisella tularensis
In 2001 only 29 tularemia cases were notified,
which is the smallest number after the national
surveillance began in 1995. The largest out-
break so far in Finland occurred the preceding
year 2000, with nearly one thousand notified
cases. The majority of cases in 2001 occurred
in the Pohjanmaa and Kymenlaakso areas.
OTHER VIRAL INFECTIONS
Puumalavirus
The cyclic nature of Puumalavirus infections
mirrors that of its reservoir the bank vole, and
usually follows a 3-year cycle, with 2 years of
high numbers of cases, followed by 1 year with
lower numbers. In Finland, 2001 represented
the first in a 2-year high cycle, with 1057 noti-
fied cases, following 774 cases in 2000. Since
laboratory-confirmed data have been collected
for the NIDR system in 1995, the highest num-
bers of cases have been observed in the 2-year
cycle for 1998 (1305) and 1999 (2300).
As in previous years, in 2001 most cases
were observed in males, with an overall
male:female ratio of 1.8 : 1.  Most male cases
(69%) were between 25 and 54 years old, while
most female cases (71%) were aged between
30 and 59 years.
In 2001, the numbers of cases of
Puumalavirus followed the usual trend of in-
creasing as winter approached (October to
December), and were at their lowest in Febru-
ary-April. This can be explained by the move-
ment of the bank vole population, which has
greatest human contact during early winter
months (when they start to enter buildings for
warmth) and their low prevalence during and
at the end of winter (when they are still in hi-
bernation).
As to be expected from the transmission
route and reservoir of this infection, Puumala-
virus has a noticeable geographical distribu-
tion in Finland. In 2001 the highest rates of in-
fection (over 69 per 100 000) were seen in Itä-,
Etelä- and Pohjois-Savo healthcare districts in
the east of the country, compared with very
low rates (below 10 per 100 000) in the South-
west of Finland.
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Ahvenanmaa
Tick-borne encephalitis (TBE)
The all-time record year 2000 was followed
by another year of exceptionally high inci-
dence: in 2001 the number of notified TBE
cases (33) was several times higher than the
long-term average, especially if compared to
figures from 1980s before the current notifi-
cation system. Increased incidences have
been reported from several countries around
the Baltic Sea and may be a result of climatic
changes.
TBE is a serious disease; up to 40 per cent
of clinically ill patients suffer from serious
and long-term sequaleae. Clinically severe
cases are more common among elderly vic-
tims although seroprevalence studies suggest
that infections are as common in all age
groups.
Ahvenanmaa is still the black spot for the dis-
ease. In 2001 21 of the notified 33 cases were
from Ahvenanmaa. Also the southwestern ar-
chipelago is a risk area, but incident cases have
even been reported from other areas on the
southern and western coast. It seems possible
that new disease foci may emerge: Recently both
in Sweden and Germany disease clusters have
been detected in new areas.
An effective vaccine is available. Vaccina-
tion of the entire adult population of
Ahvenanmaa may prove necessary if the
current increasing trend continues.
Figure 15.
Tick-borne encephalitis cases notified in Ahvenanmaa and the rest of Finland in 1995-2001
Cases notified
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MALARIA
Malaria
38 cases of malaria were diagnosed in Finland
in 2001. The species was Plasmodium falciparum
in 16 cases, P. vivax in 16 cases and P. ovale in
six cases.
Most of the infections (22 cases, 58%)
and all of the P. falciparum infections were ac-
quired in Africa. Eleven of them were acquired
in West Africa, six in East Africa and five in
central or southern Africa. Most of the P. vivax
infections, eight cases, came from India and
Pakistan. Five cases of P. vivax malaria were
acquired in Indonesia. Two of these were ac-
quired in the island of Sumba and three in the
island of Lombok. One case of P. vivax malaria
came from East Timor, one from Papua New
Guinea and one from southern Africa. One of
the P. ovale cases came from Guyana, and the
other five cases came from Africa.
Most of the patients (26 patients, 69%)
were Finnish citizens. Eighteen of them
(47%)had been on a trip shorter than six
months to malaria endemic areas. Seven pa-
tients were former immigrants and their fam-
ily members who went to visit relatives in
West Africa and did not take malaria prophy-
laxis. Eight immigrants from malaria endemic
areas fell ill with malaria after coming to Fin-
land for the first time. Four of the patients were
Finns living in malaria endemic areas
Most of the patients (30 patients, 79%)
had not taken malaria prophylaxis or had
taken it irregularly.
Eight persons fell ill with malaria in spite
of regular drug prophylaxis. Three had P. ovale
and two had P. vivax infection. Only three of
the patients had P. falciparum malaria in spite
of regular drug prophylaxis, and in their case
there was reason to suspect drug-resistant P.
falciparum malaria. All of them came from Af-
rica and they had used chloroquine either
alone or with proguanil.
The annual number of imported malaria
cases and the countries of origin has remained
relatively constant over the past few years in
Finland.
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Findings in blood and cerebrospinal fluid
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Table 14.
Blood culture findings in 1995-2001,  adults (> 15 years)
Microbe/microbe group 1995 1996 1997 1998 1999 2000 2001
Bacteria
Escherichia coli 1264 1374 1496 1462 1559 1565 1791
Staphylococcus aureus 556 610 671 637 727 792 835
Staphylococcus, other than aureus 518 576 549 573 653 785 809
Streptococcus pneumoniae 386 426 489 466 473 494 554
Enterococcus ssp. 226 250 261 280 286 321 388
Klebsiella ssp. 235 248 274 283 281 316 355
Streptococcus viridans group (S. milleri, S. bovis) 218 235 268 267 293 305 306
Pseudomonas ssp. 225 197 197 180 198 209 209
Enterobacter ssp. 94 130 152 159 137 154 189
Bacteroides ssp. 137 132 170 153 184 174 179
Streptococcus, other beta-hemolytic (C and G) 91 125 151 132 161 146 171
Streptococcus agalactiae 65 82 97 101 111 116 137
Streptococcus pyogenes 54 52 77 94 103 106 88
Clostridium ssp. 79 66 83 68 68 77 81
Diphteroids and propionibacteria 29 49 54 76 63 89 66
Haemophilus ssp. 10 19 19 29 30 32 49
Salmonella ssp. 46 28 23 31 49 24 39
Bacillus 14 17 13 18 15 36 37
Fusobacterium ssp. 23 22 23 34 28 23 32
Acinetobacter ssp. 28 33 24 18 24 31 27
Stenotrophomonas maltophilia 20 27 18 8 12 15 23
Neisseria meningitidis 27 30 10 13 22 18 23
Listeria monocytogenes 23 23 41 38 37 16 22
Campylobacter ssp. 12 14 10 11 10 14 17
Capnocytophaga canimorsus 4 5 10 3 8 6 7
Mycobacteria 15 11 1 8 - 6 6
Yersinia enterocolitica and pseudotuberculosis 3 8 4 9 8 4 6
Other enterobacteria 130 130 149 137 140 185 204
Other gram-positive bacilli 26 23 22 29 28 39 28
Other gram-positive cocci 60 58 44 62 58 62 57
Other gram-negative anaerobes - 2 3 8 9 5 3
Other gram-negative bacteria 43 48 41 48 50 48 43
Other undefinable bacteria - - 1 1 - - 1
Bacteria, total: 4661 5050 5445 5436 5825 6213 6782
Fungi
Candida albicans 46 63 63 59 70 82 92
Other yeasts 28 17 23 31 35 42 49
Other fungi 2 - 2 7 1 - 1
Fungi, total: 76 80 88 97 106 124 142
Total: 4737 5130 5533 5533 5931 6337 6924
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Table 15.
Blood culture findings in 1995-2001, children   (0-14 years)
Microbe/microbe group 1995 1996 1997 1998 1999 2000 2001
Bacteria
Staphylococcus, other than aureus 114 92 102 102 141 141 144
Streptococcus pneumoniae 92 98 88 77 77 98 91
Staphylococcus aureus 71 57 76 81 85 59 52
Escherichia coli 63 49 59 61 53 63 44
Streptococcus agalactiae 46 52 43 48 42 39 41
Streptococcus viridans group, S. milleri and S. bovis 35 35 36 32 33 27 34
Pseudomonas ssp. 4 8 10 11 2 7 12
Neisseria meningitidis 6 17 10 14 16 17 12
Streptococcus pyogenes 4 8 3 11 13 10 11
Enterococcus ssp. 21 19 12 14 12 10 11
Klebsiella ssp. 9 13 15 11 14 11 10
Enterobacter ssp. 13 10 10 10 12 8 6
Acinetobacter ssp. 7 5 4 6 7 6 5
Haemophilus ssp. 2 6 3 5 6 4 5
Bacillus 5 6 5 2 4 10 4
Diphteroids and propionibacteria 2 - 4 4 6 4 2
Stenotrophomonas maltophilia 1 - 6 6 2 2 2
Bacteroides ssp. 1 2 1 3 2 5 2
Streptococcus, other betahemolytic (C ja G) 3 - 1 6 1 2 1
Clostridium ssp. 4 1 2 4 1 1 1
Listeria monocytogenes 1 2 2 2 - 1 1
Salmonella ssp. 3 2 1 3 7 1 1
Campylobacter ssp. - - - - 2 2 1
Fusobacterium ssp. 1 6 4 2 5 4 1
Mycobacteria - - - - - - -
Yersinia enterocolitica and pseudotuberculosis 2 - - - - - -
Capnocytophaga canimorsus - - - - - - -
Other enterobacteria 6 4 5 4 8 10 3
Other gram-positive bacilli 1 2 2 2 3 2 3
Other gram-positive cocci 4 7 5 7 15 12 9
Other gram-negative anaerobes - 1 - - 1 - -
Other gram-negative bacteria 2 5 5 8 4 3 3
Other undefinable bacteria - - - 1 - - -
Bacteria, total: 523 507 514 537 574 559 512
Fungi
Candida albicans 11 4 3 3 13 7 4
Other yeasts 4 3 1 2 9 10 8
Other fungi - - 3 1 1 - -
Fungi, total: 15 7 7 6 23 17 12
Total: 538 514 521 543 597 576 524
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Table 16.
Cerebrospinal fluid culture findings in  1995-2001, adults (> 15 years)
Microbe/microbe group 1995 1996 1997 1998 1999 2000 2001
Bacteria
Staphylococcus, other than aureus 7 15 13 31 36 34 53
Streptococcus pneumoniae 22 25 25 28 22 22 28
Neisseria meningitidis 35 39 21 20 19 13 13
Staphylococcus aureus 1 13 9 14 15 12 11
Diphteroids and propionibacteria - 1 1 8 3 5 7
Pseudomonas ssp. - - 4 3 5 5 7
Enterococcus ssp. 1 1 4 5 4 4 5
Streptococcus viridans group, S. milleri and S. bovis 1 5 3 6 4 5 4
Listeria monocytogenes 9 4 7 10 3 4 4
Bacillus - - 1 2 1 3 4
Enterobacter ssp. 1 - 2 2 1 1 4
Haemophilus ssp. - 2 5 3 3 3 4
Streptococcus agalactiae 1 4 - - 1 4 2
Streptococcus, other betahemolytic (C and G) - 4 - - 1 - 2
Klebsiella ssp. - 2 4 1 2 2 2
Acinetobacter ssp. - - 3 2 1 - 2
Mycobacteria 2 1 1 1 - 4 1
Escherichia coli 2 1 4 1 4 3 1
Salmonella ssp. - - - 2 - - 1
Yersinia enterocolitica and pseudotuberculosis - - - - 1 - -
Stenotrophomonas maltophilia 1 - - - - - -
Campylobacter ssp. - - - 1 - - -
Capnocytophaga canimorsus - 1 - 1 - - -
Bacteroides ssp. - - - - 1 - -
Fusobacterium ssp. - 1 - - 1 1 -
Other enterobacteria - - 1 - 1 2 3
Other gram-positive bacilli 2 1 - - - - -
Other gram-positive cocci - 2 1 2 2 1 1
Other gram-negative anaerobes - - - - - - -
Other gram-negative bacteria - 1 - 1 - 2 2
Other undefinable bacteria - - - - - 2 1
Bacteria, total: 85 123 109 144 131 132 162
Fungi
Candida albicans - 1 - 1 2 2 -
Other yeasts 1 1 - - 2 1 2
Other fungi - - - 1 - - -
Fungi, total: 1 2 - 2 4 3 2
Total: 86 125 109 146 135 135 164
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Table 17.
Cerebrospinal fluid culture findings in 1995-2001, children (0-14  years)
Microbe/microbe group 1995 1996 1997 1998 1999 2000 2001
Bacteria
Neisseria meningitidis 10 9 12 16 11 11 9
Staphylococcus aureus 3 2 7 3 2 2 7
Staphylococcus, other than aureus 2 8 6 8 14 12 5
Streptococcus agalactiae 2 8 2 9 5 4 3
Streptococcus pneumoniae 12 8 4 7 11 3 3
Streptococcus viridans group, S. milleri and S. bovis 4 - 1 2 - 2 3
Escherichia coli - 1 2 3 1 1 3
Haemophilus ssp. 3 1 - 3 2 2 3
Streptococcus pyogenes - - 1 - 1 - 1
Enterococcus ssp - 1 4 1 2 1 -
Listeria monocytogenes - 1 - 1 - - -
Bacillus - - - - - 1 -
Diphteroids and propionibacteria - - - - - 1 -
Klebsiella ssp. - - - - - 1 -
Salmonella ssp. - - - - 1 - -
Pseudomonas ssp. - - - 1 - - -
Stenotrophomonas maltophilia - 1 - - - - -
Acinetobacter ssp. - - 2 - 1 - -
Bacteroides ssp. - - - - 1 - -
Other enterobacteria - - 1 2 - - -
Other gram-positive cocci - 2 2 - 1 - 3
Other gram-negative bacteria - 1 - - - - 1
Other undefinable bacteria - - - - - 1 -
Bacteria, total: 36 43 44 56 53 42 41
Fungi
Candida albicans - - - - - - -
Other yeasts - - - - - - -
Other fungi - - - 1 - - -
Fungi, total: - - - 1 - - -
Total: 36 43 44 57 53 42 41
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